Fenelon G, Andries E, Brugada P
Cardiovascular Research and Teaching Institute Aalst, O.L.V. Hospital, Belgium.
Indian Heart J. 1994 May-Jun;46(3):123-8.
Catheter ablation has become established as a gold standard therapy for patients suffering from many supraventricular and ventricular arrhythmias, offering a curative alternative to these patients by way of destroying or isolating the arrhythmia substrate. Radiofrequency has been used as a primary source of energy for transcatheter ablation due to its safety and efficacy. Another technique is transcoronary chemical ablation, consisting of the infusion of ethanol through the coronary blood supply to the site of origin of the arrhythmia. Most supraventricular arrhythmias like atrial tachycardia, atrioventricular nodal reentrant tachycardia and arrhythmias related to atrioventricular accessory pathways can be managed with radiofrequency catheter ablation. However, some concerns exist regarding the value of this technique for the treatment of atrial flutter and ventricular tachycardia. In this review we discuss the state-of-the-art in catheter ablation of cardiac arrhythmias and its future perspectives.
导管消融已成为治疗许多室上性和室性心律失常患者的金标准疗法,通过破坏或隔离心律失常基质为这些患者提供了一种治愈性选择。由于其安全性和有效性,射频已被用作经导管消融的主要能量来源。另一种技术是经冠状动脉化学消融,即通过冠状动脉血供向心律失常起源部位注入乙醇。大多数室上性心律失常,如房性心动过速、房室结折返性心动过速以及与房室旁路相关的心律失常,都可以通过射频导管消融进行治疗。然而,对于该技术治疗心房扑动和室性心动过速的价值仍存在一些疑虑。在本综述中,我们讨论了心律失常导管消融的最新进展及其未来前景。